Nurix Therapeutics Inc (NRIX)
22.05
-0.32
(-1.43%)
USD |
NASDAQ |
Nov 22, 16:00
21.50
-0.55
(-2.49%)
After-Hours: 20:00
Nurix Therapeutics Profit Margin (Quarterly): -388.9% for Aug. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -388.9% |
| May 31, 2024 | -368.4% |
| February 29, 2024 | -250.3% |
| November 30, 2023 | -276.8% |
| August 31, 2023 | -200.3% |
| May 31, 2023 | -79.14% |
| February 28, 2023 | -321.1% |
| November 30, 2022 | -688.7% |
| August 31, 2022 | -423.6% |
| May 31, 2022 | -397.1% |
| February 28, 2022 | -442.1% |
| Date | Value |
|---|---|
| November 30, 2021 | -509.8% |
| August 31, 2021 | -281.3% |
| May 31, 2021 | -372.0% |
| February 28, 2021 | -484.4% |
| November 30, 2020 | -297.7% |
| August 31, 2020 | -453.3% |
| May 31, 2020 | |
| February 29, 2020 | -432.6% |
| November 30, 2019 | -726.0% |
| August 31, 2019 | -22.94% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-726.0%
Minimum
Nov 2019
-79.14%
Maximum
May 2023
-389.1%
Average
-388.9%
Median
Aug 2024
Profit Margin (Quarterly) Benchmarks
| Enzo Biochem Inc | -177.8% |
| Neogen Corp | -5.81% |
| Pfizer Inc | 25.22% |
| Zymeworks Inc | -186.6% |
| Accolade Inc | -22.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.52% |
| Return on Assets | -44.22% |
| Return on Invested Capital | -65.52% |
| Operating Margin (Quarterly) | -433.8% |
| Return on Net Operating Assets | -404.7% |